Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis

NCT07339111 is registered in ClinicalTrials.gov with Medipost, Inc. as lead sponsor.

NCT NCT07339111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07339111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis
Lead sponsor
Medipost, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
March 11, 2026
Completion date
June 30, 2029
Enrollment
300 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

knee cartilage defects